Wedmont Private Capital Lowers Position in West Pharmaceutical Services, Inc. (NYSE:WST)

Wedmont Private Capital cut its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WSTGet Rating) by 14.8% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,083 shares of the medical instruments supplier’s stock after selling 188 shares during the period. Wedmont Private Capital’s holdings in West Pharmaceutical Services were worth $327,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its position in shares of West Pharmaceutical Services by 1.0% in the first quarter. Vanguard Group Inc. now owns 8,716,312 shares of the medical instruments supplier’s stock valued at $3,579,876,000 after acquiring an additional 82,459 shares in the last quarter. BlackRock Inc. lifted its position in shares of West Pharmaceutical Services by 8.9% in the fourth quarter. BlackRock Inc. now owns 8,094,288 shares of the medical instruments supplier’s stock valued at $3,796,302,000 after acquiring an additional 664,275 shares in the last quarter. State Street Corp lifted its position in shares of West Pharmaceutical Services by 1.6% in the fourth quarter. State Street Corp now owns 3,455,709 shares of the medical instruments supplier’s stock valued at $1,620,762,000 after acquiring an additional 54,510 shares in the last quarter. WCM Investment Management LLC lifted its position in shares of West Pharmaceutical Services by 0.8% in the first quarter. WCM Investment Management LLC now owns 1,526,481 shares of the medical instruments supplier’s stock valued at $626,941,000 after acquiring an additional 11,655 shares in the last quarter. Finally, Geode Capital Management LLC lifted its position in shares of West Pharmaceutical Services by 3.0% in the fourth quarter. Geode Capital Management LLC now owns 1,382,016 shares of the medical instruments supplier’s stock valued at $646,546,000 after acquiring an additional 40,280 shares in the last quarter. 91.98% of the stock is currently owned by hedge funds and other institutional investors.

West Pharmaceutical Services Trading Up 0.7 %

Shares of WST stock opened at $269.93 on Tuesday. West Pharmaceutical Services, Inc. has a 12-month low of $261.31 and a 12-month high of $475.00. The company has a current ratio of 3.13, a quick ratio of 2.41 and a debt-to-equity ratio of 0.09. The stock’s 50-day moving average price is $312.53 and its 200-day moving average price is $330.25. The stock has a market capitalization of $19.99 billion, a price-to-earnings ratio of 29.96, a price-to-earnings-growth ratio of 1.08 and a beta of 1.18.

West Pharmaceutical Services (NYSE:WSTGet Rating) last issued its quarterly earnings data on Thursday, July 28th. The medical instruments supplier reported $2.47 earnings per share for the quarter, topping the consensus estimate of $2.19 by $0.28. West Pharmaceutical Services had a return on equity of 29.08% and a net margin of 23.41%. The company had revenue of $771.30 million for the quarter, compared to analysts’ expectations of $754.25 million. During the same period in the previous year, the firm posted $2.46 earnings per share. The firm’s revenue for the quarter was up 6.6% on a year-over-year basis. Equities research analysts predict that West Pharmaceutical Services, Inc. will post 9.09 EPS for the current fiscal year.

Insider Activity at West Pharmaceutical Services

In related news, insider Silji Abraham sold 5,374 shares of the business’s stock in a transaction that occurred on Monday, August 1st. The stock was sold at an average price of $343.93, for a total value of $1,848,279.82. Following the completion of the sale, the insider now owns 3,201 shares in the company, valued at $1,100,919.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.60% of the stock is owned by company insiders.

West Pharmaceutical Services Profile

(Get Rating)

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.

Featured Articles

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.